Table 2. The susceptibility for strains of E. coli J53AzR, Kp1241, Kp1769, and transconjugants (J53AzR-Kp1241 and J53AzR-Kp1769).
Antimicrobial agent | MIC (µg/mL) | ||||
E.coli J53AzR | Kp1241 | Kp1769 | J53AzR-Kp1241 | J53AzR-Kp1769 | |
Ciprofloxacin | 0.0025 | 16 | 0.25 | 4 | 0.0625 |
Levofloxacin | 0.0025 | 16 | 0.25 | 8 | 0.625 |
Amikacin | 0.25 | 128 | 2 | 32 | 1 |
Tobramycin | 0.025 | 64 | 1 | 32 | 0.5 |
Gentamicin | 0.25 | 32 | 1 | 16 | 0.5 |
Ampicillin | 0.050 | 64 | 128 | 32 | 32 |
Aztreonam | 0.50 | 128 | 2 | 32 | 1 |
Cefotetan | 0.0125 | 128 | 64 | 32 | 16 |
Cefazolin | 0.50 | 128 | 64 | 64 | 16 |
Cefepime | 0.0125 | 128 | 1 | 32 | 0.625 |
Ceftazidime | 0.050 | 16 | 2 | 8 | 1 |
Ceftriaxone | 0.025 | 128 | 16 | 32 | 4 |
Imipenem | 0.25 | 16 | 2 | 8 | 1 |
Meropenem | 0.25 | 16 | 2 | 8 | 1 |
Ertapenem | 0.50 | 32 | 4 | 16 | 2 |
Ampicillin/Sulbactam | 0.050 | 128 | 64 | 32 | 16 |
Piperacillin/Tazobactam | 0.025 | 256 | 16 | 64 | 4 |
Cefoperazone/Sulbactam | 0.0125 | 128 | 2 | 32 | 0.5 |
Polymyxin B | 0.006 | 0.5 | 0.25 | 0.125 | 0.0625 |
Colistin | 0.0125 | 1 | 0.5 | 0.25 | 0.125 |
Clinical breakpoints of MICs for the antimicrobial agents see the reference [25].